✦ LIBER ✦

Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients

✍ Scribed by Palacios, Rosario ;Aguilar, Isabel ;Hidalgo, Ana ;Santos, Jesús

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of emtricita

✍ Rainel Sánchez-de la Rosa; Luis Herrera; Santiago Moreno 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 704 KB

Long-term effectiveness and safety of di

✍ Christian Laurent; Jules Brice Tchatchueng Mbougua; Ndèye Fatou Ngom Guèye; Jean 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB

Clinical Trial Report: TMC278 (Rilpiviri

✍ Rodger D. MacArthur 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 75 KB

Safety and efficacy of Tenofovir/Emtrici

✍ Pammi, M.; Arumainayagam, J.; Kumari, B.; Ahmed-Jushuf, I.; Carlin, E. M; Chandr 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Rilpivirine, emtricitabine and tenofovir

✍ Lambert-Niclot, S.; Charpentier, C.; Storto, A.; Fofana, D.; Soulie, C.; Fourati 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 179 KB

Resistance development over 144 weeks in

✍ NA Margot; B Lu; A Cheng; MD Miller; the Study 903 Team 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB